Related Experiment Video
Updated: Jun 13, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
Development and validation of a stability indicating capillary electrophoresis method for the determination of
I I Hamdan1, A K Bani Jaber, A M Abushoffa
1Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman, Jordan. iimad68@yahoo.com
Abstract:
A simple and a stability indicating capillary electrophoresis method was developed and validated for the analysis of metformin hydrochloride in tablet formulation. The method employed 40 mM citrate buffer at pH 6.7 as a background electrolyte with an applied voltage of 15 kV (positive polarity). The capillary used was of 68.5 cm length (60 cm to detector) and the detection wavelength was 230 nm. The method was validated in accordance with the ICH requirements, which involved accuracy, precision, linearity, selectivity and both limit of detection and limit of quantitation. The current method was linear over the concentration range of 0.2-2.0mg/ml of metformin hydrochloride. The method was precise as reflected by inter-day and intra-day relative standard deviation (RSD) of less than 2%. The limit of detection and limit of quantitation were 2.0 microg/ml and 8.0 microg/ml, respectively. The stability indicating capability of the method was established by enforced degradation studies combined with peak purity assessment using photodiode array detection.
Related Concept Videos
Data Validation
Key parameters for method validation include:
Capillary Electrophoresis: Applications
Capillary zone electrophoresis (CZE) separates ionic components based on their electrophoretic mobility. It has been used to separate proteins, amino acids,...
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
In Vitro Drug Release Testing: Overview, Development and Validation
Electrophoresis: Overview
There...
In Vitro Drug Dissolution: Compendial Testing Models II
